These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36526853)

  • 1. An Interlaboratory Study to Identify Potential Visible Protein-Like Particle Standards.
    Telikepalli SN; Carrier MJ; Ripple DC; Barnett G; Bhirde A; Bolton D; Bou-Assaf GM; Ferrari E; Leigh S; Levitskaya-Seaman S; Menzen T; Nikels F; Riley A; Saggu M; Sahni N; Vernooij E; Wuchner K
    AAPS PharmSciTech; 2022 Dec; 24(1):18. PubMed ID: 36526853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Protein-Like Reference Material for Semiquantitatively Monitoring Visible Proteinaceous Particles in Biopharmaceuticals.
    Telikepalli S; Gonzalez K; Dragulin-Otto S; Ripple D; Carrier M; Khan M
    PDA J Pharm Sci Technol; 2019; 73(5):418-432. PubMed ID: 31209163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semi-Quantitative Analysis of Inherent Visible Particles for Biopharmaceutical Products.
    Cash PW; Narwal R; Levitskaya SV; Krause S; Murphy D; Mazaheri M
    PDA J Pharm Sci Technol; 2016; 70(2):134-42. PubMed ID: 26797974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Biopharmaceutical Industry Perspective on the Control of Visible Particles in Biotechnology-Derived Injectable Drug Products.
    Mathonet S; Mahler HC; Esswein ST; Mazaheri M; Cash PW; Wuchner K; Kallmeyer G; Das TK; Finkler C; Lennard A
    PDA J Pharm Sci Technol; 2016; 70(4):392-408. PubMed ID: 27091885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An interlaboratory comparison of sizing and counting of subvisible particles mimicking protein aggregates.
    Ripple DC; Montgomery CB; Hu Z
    J Pharm Sci; 2015 Feb; 104(2):666-77. PubMed ID: 25421933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Interlaboratory Comparison on the Characterization of a Sub-micrometer Polydisperse Particle Dispersion.
    Benkstein KD; Balakrishnan G; Bhirde A; Chalus P; Das TK; Do N; Duewer DL; Filonov N; Cheong FC; Garidel P; Gill NS; Grabarek AD; Grier DG; Hadley J; Hollingsworth AD; Howard WW; Jarzębski M; Jiskoot W; Kar SR; Kestens V; Khasa H; Kim YJ; Koulov A; Matter A; Philips LA; Probst C; Ramaye Y; Randolph TW; Ripple DC; Romeijn S; Saggu M; Schleinzer F; Snell JR; Tatarkiewicz JK; Wright HA; Yang DT
    J Pharm Sci; 2022 Mar; 111(3):699-709. PubMed ID: 34808214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Particle electrophoresis for quality assurance and process control.
    Seaman GV; Knox RJ
    Electrophoresis; 2001 Feb; 22(3):373-85. PubMed ID: 11258742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micro-flow imaging multi-instrument evaluation for sub-visible particle detection.
    Fawaz I; Schaz S; Boehrer A; Garidel P; Blech M
    Eur J Pharm Biopharm; 2023 Apr; 185():55-70. PubMed ID: 36708971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving Diameter Accuracy for Dynamic Imaging Microscopy for Different Particle Types.
    Cavicchi RE; Ripple DC;
    J Pharm Sci; 2020 Jan; 109(1):488-495. PubMed ID: 31628920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical Considerations for Detection and Characterization of Sub-Micron Particles in Protein Solutions by Nanoparticle Tracking Analysis.
    Gruia F; Parupudi A; Polozova A
    PDA J Pharm Sci Technol; 2015; 69(3):427-39. PubMed ID: 26048748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Points to Consider: Best Practices to Identify Particle Entry Routes along the Manufacturing Process for Parenteral Formulations.
    Anger S; Begat C; Crnko V; Fantozzi G; Farach W; Fitzpatrick S; Gallagher B; Huelsmann S; Kinsey P; Langlade V; Lefevre G; Legendre E; McLean K; Miller J; Patel R; Perry A; Soukiassian H; Stanton A; Streich D; Timmons C; Vaneylen D; van Hoose T; Wildling L; Windover M
    PDA J Pharm Sci Technol; 2019; 73(6):635-647. PubMed ID: 31420504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical review of analytical methods for subvisible and visible particles.
    Narhi LO; Jiang Y; Cao S; Benedek K; Shnek D
    Curr Pharm Biotechnol; 2009 Jun; 10(4):373-81. PubMed ID: 19519412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The scientific basis for visible particle inspection.
    Knapp JZ
    PDA J Pharm Sci Technol; 1999; 53(6):291-302. PubMed ID: 10754727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NUSIMEP-7: uranium isotope amount ratios in uranium particles.
    Truyens J; Stefaniak EA; Aregbe Y
    J Environ Radioact; 2013 Nov; 125():50-5. PubMed ID: 23548475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP Toxicity Study Report on the atmospheric characterization, particle size, chemical composition, and workplace exposure assessment of cellulose insulation (CELLULOSEINS).
    Morgan DL
    Toxic Rep Ser; 2006 Aug; (74):1-62, A1-C2. PubMed ID: 17160106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a new series of agricultural/food reference materials for analytical quality control of elemental determinations.
    Ihnat M
    J AOAC Int; 1994; 77(6):1605-27. PubMed ID: 7819768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conducting Clinical Risk Assessments for Visible Particulate Matter in Parenteral Preparations.
    Ayres JD
    PDA J Pharm Sci Technol; 2018; 72(6):626-639. PubMed ID: 30158238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interlaboratory comparison of nanoparticle size measurements between NMIJ and NIST using two different types of dynamic light scattering instruments.
    Takahashi K; Kramar JA; Farkas N; Takahata K; Misumi I; Sugawara K; Gonda S; Ehara K
    Metrologia; 2019; 56(5):. PubMed ID: 32116391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle tracking analysis of particle size and concentration detection in suspensions of polymer and protein samples: Influence of experimental and data evaluation parameters.
    Gross J; Sayle S; Karow AR; Bakowsky U; Garidel P
    Eur J Pharm Biopharm; 2016 Jul; 104():30-41. PubMed ID: 27108267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reference material development for calibration and verification of image-based particle analyzers.
    Sharma DK; King D; Merchant C
    Int J Pharm; 2011 Sep; 416(1):293-5. PubMed ID: 21726613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.